海外の治験の状況「前立腺癌」での検索結果
403件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- A pilot study evaluating focal irreversible electroporation as treatment for participants with recurrent prostate cancer after radiotherapy.
- Recurrent Prostate Cancer
- Australia
- 2017-06-02
Not recruiting
- Survey of Prostate Cancer in Accra, Ghana
- Prostate Cancer
- Ghana, United States
- 2006-06-19
Not recruiting
- Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
- Prostate Cancer
- South Africa, United States
- 2000-11-06
Not recruiting
- Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer
- Prostatic Neoplasm
- Australia, Belgium, Canada, Chile, Czech Republic, France, Italy, Mexico, Netherlands, Poland, Portugal, Spain, United Kingdom
- 2005-09-13
Not recruiting
- Phase 0 Trial of Gallium-68 tris-hydroxypyridinone prostate specific membrane antigen (Ga-68 THP-PSMA) positron emission tomography (PET) scanning for prostate cancer
- prostate cancer
- Australia
- 2015-12-03
Not Recruiting
- A Randomized, Double-Blind, Parallel-Group Trial Comparing Bicalutamide (Casodex) 150mg Once Daily With Placebo in Patients With Non-metastatic Prostate Cancer
- Non-Metastatic Prostate Cancer;C61 - Malignant neoplasm of prostate
- Australia, Austria, Belgium, Czech Republic, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Poland, Portugal, South Africa, Spain, United Kingdom
- 2015-11-12
Not Recruiting
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer
- Neoplasms, Prostate;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom, United States
- 2015-11-12
Recruiting
- A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
- Metastatic Castration Resistant Prostate Cancer
- Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Spain, United Kingdom, United States
- 2016-11-19
Not recruiting
- A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
- Prostatic Neoplasms
- Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2018-12-05
Recruiting
- A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
- Prostate Cancer
- Australia, Denmark, Germany, Korea, Republic of, Netherlands, Puerto Rico, Romania, Spain, United Kingdom, United States
- 2018-09-18